• Home
  • Board Of Directors
  • Investors
    • Disclosures Under Regulation 46 of The LODR
  • Annual Reports
  • Contact Us


  •  Omkar Pharmachem Limited was established in year 1995.

  •  The Company has been listed in BSE (Bombay Stock Exchange) and Erstwhile listed on ASE (Ahmedabad Stock Exchange).





1. Mr. Parminder Sharma
 

Mr. Parminder Sharma, aged 43 years is a qualified person having about 19 years of experience in corporate field. He is a director of the company since 14 thNovember, 2003.

2. Bhawani Shankar Goyal
 

Mr. Bhawani Shankar Goyal appointed as Managing Director on 14-02-2020. He is graduate in Commerce from Maharshi Dayanand University and having vast experience of more than 16 years in the area of Accounts and Business Administrative.

3. Mamta Pachauri
 

Ms. Mamta Pachauri, aged 45 years is 12th pass. She is appointed as Non- executive Independent woman director for another term of five consecutive years commencing from June 29 2020 to June 28 2025.

 

4. Janak Raj Sharma
 

Mr. Janak Raj Sharma aged 64 years has rich experience in the field of Corporate Management and Advisory. He is Non executive independent Director of company and reappointment for second term of five consecutive years commencing from 13th February 2021 to 12th February 2026.




  • Ballot Forms
  • Attention of Physical Shareholders
  • Postal Ballot Result
  • Scrutinizer Report
    • Scrutinizer report & E-voting Results_2020-21
    • Scrutinizer report & E-voting Results_2019-20
    • Scrutinizer report & E-voting Results_2018-19
    • Scrutinizer report & E-voting Results_2017-18
    • Scrutinizer report & E-voting Results_2016-17
    • Scrutinizer report & E-voting Results_2015-16
    • Scrutinizer report & E-voting Results_2021-22
  • Notices
    • Board Meeting 14.02.2023
    • Board Meeting 14.11.2022
    • Board Meeting 11.08.2022
    • Board Meeting 30.05.2022
    • Board Meeting 14.02.2022
    • Board Meeting 01.11.2021
    • Board Meeting 21.06.2021
    • Board Meeting 12.08.2021
    • Board Meeting 12.02.2021
    • Board Meeting 12.11.2020
    • Board Meeting 15.09.2020
    • Board Meeting 29.06.2020
    • Board Meeting 14.02.2020
    • Board Meeting 14.11.2019
    • Board Meeting 14.08.2019
    • Board Meeting 30.05.2019
    • Board Meeting 14.02.2019
    • Board Meeting 14.11.2018
    • Board Meeting 30.05.2018
    • Board Meeting 14.02.2018
    • Board Meeting 14.12.2017
    • Board Meeting 14.09.2017
    • Board Meeting 30.05.2017
    • Board Meeting 14.02.2017
    • Board Meeting 14.11.2016
    • Board Meeting 14.08.2016
    • Board Meeting 30.05.2016
    • 21st AGM Notice
    • 22nd AGM Notice
    • 23rd AGM Notice
    • 24th AGM Notice
    • 25th AGM Notice
    • 26th AGM Notice
    • 27th AGM Notice
  • Corporate Policies
    • Nomination and Remuneration Policy
    • Policy on Prohibition of Insider Trading
    • Chairman Speech
    • Whitser Blower Policy
    • Policy On Related Party Transactions
    • Policy on Materiality of Events and Information
  • Code of Conduct of BOD & Senior Management
    • Code of Conduct of BOD & Senior Management
  • Terms and Conditions of appointment of Independent Director
    • Terms and Conditions of appointment of Independent Director
  • Familiarization Programme For Independent Director
    • Familiarization Programme For Independent Director
  • Important Dates
  • BSE Code - 532167, ASE Code- 42227
  • Commencement Certificate
  • Certificate of Incorporation
  • Quarterly compliance
    • 31st December 2022
      • Corporate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
    • 30th September 2022
      • Corporate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
      • Related Party Transaction
    • 30th June 2022
      • Corporate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
    • 31st March 2022
      • Corporate Governance Report
      • Share Holding Pattern
      • Audited Quarterly Yearly Financial Results
      • Related Party Transaction
    • 31st December 2021
      • Corporate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
    • 30th September 2021
      • Corporate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
      • Related Party Transaction
    • 30th June 2021
      • Corporate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
    • 31st March 2021
      • Corporate Governance Report
      • Share Holding Pattern
      • Audited Quarterly Yearly Financial Result
    • 31st December 2020
      • Corporate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
    • 30th Sept 2020
      • Corporate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
      • Related Party Transaction
    • 3oth June 2020
      • Corporate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
    • 31st March 2020
      • Corporate Governance Report
      • Share Holding Pattern
      • Audited Quarterly Yearly Financial Result
      • Related Party Transaction
    • 31st December 2019
      • Corporate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
    • 30th Sept 2019
      • Corporate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
      • Related Party Transaction
    • 30th June 2019
      • Corprate Governance Report
      • Share Holding Pattern
      • Unaudited Quarterly Result
    • 31st March 2019
      • Corprate Governance Report
      • Share Holding Pattern
      • Audited Quarterly Yearly Financial Result
      • Related Party Transaction
    • 31st Dec 2018
      • Corprate Governance Report
      • Unaudited Quarterly Resultst
      • Share Holding Pattern
    • 30th Sept 2018
      • Corprate Governance Report
      • Unaudited Quarterly Resultst
      • Share Holding Pattern
    • 30th June 2018
      • Corprate Governance Report
      • Unaudited Quarterly Resultst
      • Share Holding Pattern
    • 31st March 2018
      • Corporate Governance Report
      • Share Holding Pattern
      • Audited Quarterly Yearly Financial Result
    • 31st Dec 2017
      • Corporate Governance Report
      • Unaudited Quarterly Result
      • Share Holding Pattern
    • 30th Sep 2017
      • Corporate Governance Report
      • Unaudited Quarterly Result
      • Share Holding Pattern
    • 30th June 2017
      • Corporate Governance Report
      • Unaudited Quarterly Result
      • Share Holding Pattern
    • 31st March 2017
      • Audited Quarterly/Yearly Results
      • Corporate Governance Report
      • Share Holding Pattern
    • 31st Dec 2016
      • Unaudited Quarterly Result
      • Corporate Governance Report
      • Share Holding Pattern
    • 30th Sept 2016
      • Unaudited Quarterly Result
      • Corporate Governance Report
      • Share Holding Pattern
    • 30th June 2016
      • Unaudited Quarterly Result
      • Corporate Governance Report
      • Share Holding Pattern
    • 31st March 2016
      • Audited Quarterly Result
      • Corporate Governance Report
      • Share Holding Pattern
    • 31st Dec 2015
      • Corporate Governance
      • Shareholding Pattern
    • 30th Sep 2015
      • Unaudited Quarterly Result
      • Corporate GOVERNANCE
      • Shareholding Pattern
    • 30th June 2015
      • Latest Un-Audited Quarterly Result
      • Corporate GOVERNANCE
      • Share holding Pattern
    • 31st March 2015
      • Latest Un-Audited Quarterly Result
      • Corporate GOVERNANCE
      • Share holding Pattern
    • 31st Dec 2014
      • Latest Un-Audited Quarterly Result
      • Corporate GOVERNANCE
      • Share holding Pattern
    • 30th Sep 2014
      • Latest Un-Audited Quarterly Result
      • Corporate GOVERNANCE
      • Share holding Pattern
    • 30th June 2014
      • Latest Un-Audited Quarterly Result
      • Corporate GOVERNANCE
      • Share holding Pattern
    • 31st March 2014
      • Latest Un-Audited Quarterly Result
      • Corporate GOVERNANCE
      • Share holding Pattern
    • 31st Dec 2013
      • Latest Un-Audited Quarterly Result
      • Corporate GOVERNANCE
      • Share holding Pattern
    • 30th Sep 2013
      • Latest Un-Audited Quarterly Result
      • Corporate GOVERNANCE
      • Share holding Pattern
    • 30th June 2013
      • Latest Un-Audited Quarterly Result
      • Corporate GOVERNANCE
      • Share holding Pattern
    • 31st March 2013
      • Latest Un-Audited Quarterly Result
      • Corporate GOVERNANCE
      • Share holding Pattern
  • Policies
  • Investors Grievances
    • Officers handling investors Grivances
  • Investor Correspondence
    • Investor Correspondence
  • Annual Return
    • Annual Return 31st March, 2020
    • Annual Return 31st March, 2021
    • Annual Return 31st March, 2022
  • Annual Secretarial Compliance Report
    • Annual Secretarial Compliance Report 2021-2022
    • Annual Secretarial Compliance Report 2020-2021
  • Disclosure under regulation 30 of SEBI LODR
    • AGM Proceeding OPL 2021
    • Intimation Proceeding AGM Omkar
    • Proceeding of 22nd Annual General Meeting OPL 2017
    • Proceeding of 23rd AGM Omkar 2018
    • Proceeding of AGM OPL September 2019
    • Regulation 30 Proceeding of AGM Omkar 2016
    • AGM Proceeding OPL 2022
    • CFO Resignation Intimation Omkar
    • Discloser Under Regulation 30(6) Resignation
    • Outcome of BM OPL 14-Feb-2020
    • Outcome BM OPL 2020
    • Regulation 30(6) Appointment
    • Outcome of AGM_30092015
    • Re-appointment of MD_Reg 30(6)
    • BM_Outcome Appointment of CS_2016
    • Outcome AGM_2016
    • Outcome of BM_310821




  • Annual Report 2013
  • Annual Report 2014
  • Annual Report 2015
  • Annual Report 2016
  • Annual Report 2017
  • Annual Report 2018
  • Annual Report 2019
  • Annual Report 2020
  • Annual Report 2021
  • Annual Report 2022




  • The main objects of the Company are related to pharmaceuticals, chemicals and to provide Management and business support services.
  • Currently company is engaged in business of providing support services related activities.
  • Industry structure and development
    • India's Pharmaceutical Industry: An overview -Size of India's pharmaceutical sales were an estimated $20 billion in2014 and the forecast indicates an average growth of 10.3 percent annually in 2014-18 (in nominal local-currency terms) to reach $33.8 billion. This growth will be driven by increasing personal incomes and the escalation of chronic diseases. India's pharmaceutical market is dominated by generic drugs, which account for around 75 percent of the market by volume. Supplied mainly by domestic companies, generics have helped to keep pharmaceutical prices low and the market is expected to continue expanding rapidly. Still, India's growing middle class is increasing demand for more advanced and costly medicines. Although domestic pharmaceutical companies were established primarily to supply the local market, they have taken advantage of their low labor and research costs to export generic drugs to developed countries, notably the U.S, its largest export market. India is also a major supplier to other emerging markets and has become the biggest supplier to UN health care programs. Domestic and international pharmaceutical companies operating in India face issues ranging from the new Drug Price Control Order (DPCO), which prescribes a ceiling on the prices of several essential medicines, to drug and clinical trial quality, patent issues, and the misclassification of medical devices.







  • June 2016
    • Eng news paper _BS_June Qtr
    • Notice of News Advt._Omkar_June_2016
    • Regional news paper BS_June Qtr
    • Advt.AGM,E-voting,Book-closure_2016
  • September 2016
    • Advt.Qty.REsult.300916
    • News Paper Advt _Notice of BM 300916
  • December 2016
    • Notice of Newspaper Advt_Board Meeting
    • Notice of Publication of Results_15.02.17
  • March 2017
    • News Paper Advertisment_Notice of Board Meeting
    • News Paper Advt_Financial Results
  • June 2017
    • Intimation_News paper Advertisement
    • News paper Advt of Financials_OPL
  • September 2017
    • News paper Advt_OPl_financial_Sept Qtr
    • Omkar Notice of BM Advt
  • December 2017
    • Advt.Qty.REsult.300916
    • News Paper Advt _Notice of BM 300916
  • March 2018
    • Advt.Qty.REsult.300916
    • News Paper Advt _Notice of BM 300916
  • June 2018
    • News Paper Publication_Notice ofBM_Ack
    • Publication_Advertisement_UFS_300618
  • September 2018
    • News paper Publication of Results_September_2018
    • News Paper_Advertisment_OPL_BM.pdf
    • News paper Publication
  • December 2018
    • News paper Publication_Notice of board meeting
    • News Paper_Publication_Omkar_December 2018
  • March 2019
    • News Paper Advt_Intimation of BM
    • News paper Publication of Results_Omkar_310319
  • June 2019
    • News paper Advertisement_Intimation_BM_OPL_June_2019
    • News paper Publication_OPL
  • September 2019
    • Notice of BM_Advert_OPL_Sept_2019
    • News paper Publication_OPL_Results_Sept_2019
    • News Paper Publication_OPL_2019
  • December 2019
    • OPL_News Paper Advertisment
    • Publication of Results_OPL_December2019
  • June 2020
    • Publication of Results_OPL_June_2020
    • News paper_BM_Intmation June 2020
  • September 2020
    • Notice of BM_Advert_OPL_Sept_2020
    • Notice of BM_Advert_OPL_Nov_2020
    • Publication of Results_OPL_SEPT_2020
  • December 2020
    • Notice of BM_Advert_OPL_Dec_2020
    • Publication of Results December 2020
  • June 2021
    • Notice of BM_Advert_OPL_June_21
    • Publication of Results March 2021
  • August 2021
    • Notice of BM Advert_OPL_Aug_2021
    • Publication of Results JUN 2021
  • September 2021
    • NoticeNews Paper Publication_OPL_2021
    • Publication of Results SEPT 2021
  • December 2021
    • Publication of Results DEC 2021
  • March 2022
    • Publication of Results MARCH 2022
  • June 2022
    • Publication of Results JUNE 2022
  • September 2022
    • Publication of Results SEPTEMBER 2022
    • Publication Of Results Quarter and Year Ended 30th September, 2022
  • December 2022
    • Publication of Results DECEMBER 2022





  • The composition of different committees of Board of Directors is as under:
    • Audit Committee
      • Mamta Pachauri: Chairman; Parminder Sharma: Member; Janak Raj Sharma: Member w.e.f. 13.02.2016; S. S. Bindra: Member upto 13.02.2016
    • Nomination & Remuneration Committees Composition
      • Mamta Pachauri: Chairman; Parminder Sharma: Member; Janak Raj Sharma: Member w.e.f. 13.02.2016; S. S. Bindra: Member upto 13.02.2016
    • Stake holders Relationship Committees Composition
      • Parminder Sharma: Member; Janak Raj Sharma: Member w.e.f. 13.02.2016; Ms. Mamta Pachauri member w.e.f. 30.03.2019; S. S. Bindra: Member upto 13.02.2016
    • CSR Committees composition
      • No such committee as the same is not applicable to the Company





  • Key Managerial Personnel of the Company are as under:
    • Bhawani Shankar Goyal, Managing Director, DIN-03255804, Address:H No.77,Nangal Chaudhary Teh. Narnaul,Dist- Mahindergarh, Haryana-123023
    • Gaurav Kathuria, Chief Financial Officer Address:S-59,Gali No- 2, Block S, South Anarkalikrishna Nagar Delhi 110051,Resigned from 31-August-2022
    • Pankaj Singh, Company Secretary and Compliance Officer Address: A-136, Vivek Vihar, Phase-1, East Delhi, New Delhi-110095
  • Registrar & Share Transfer Agents:
    • Alankit Assignments Limited 205-208, Anarkali Complex, Jhandewalan Extention, New Delhi – 110055
    • Email ID: lalitap@alankit.com ,Contact Nos.:011-42541958/1234/ ,Website:www.alankit.com





1. Company’s Registered Office Address:
  310, Wall Street-1,
  Near Gujarat College Cross Road,
  Ellisbridge,
  Ahmedabad, GUJARAT-380006
2. Contact Person Name and Numbers for Grievances redressal
  Company Secretary:Pankaj Mahadeo Singh +91-9155012094
3. E-mail:investors.opl@gmail.com